Peri-Implantitis Treatment Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Method Type (Surgical, Non-Surgical); By End User (Hospitals, Dental Clinics); By Region (North America, Europe, Asia Pacific,

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	200 Pages	BlueWeave Consulting	January, 2023	BLWC17631019

Best Price Guarantee
Price	from $4,850
Length	200 Pages
Publisher	BlueWeave Consulting
Published Date	January, 2023
SKU	BLWC17631019

Peri-Implantitis Treatment Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Method Type (Surgical, Non-Surgical); By End User (Hospitals, Dental Clinics); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Global Peri-Implantitis Treatment Market to Expand at Steady CAGR of 8.1% During 2023–2029
Global peri-implantitis treatment market is flourishing due to an increasing focus on treating oral disorders, predominance of peri-implantitis, and growing use of advanced oral technologies.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, expects global peri-implantitis treatment market size to grow at a steady CAGR of 8.1% during the forecast period between 2023 and 2029. Major factors for the expansion of global peri-implantitis treatment market include increasing usage of dental implants for prosthetic rehabilitation, rise in the number of oral diseases, and increase in prevalence of peri-implantitis. Growing public awareness of oral hygiene has caused a rise in dental visits, which is expected to drive demand for peri-implantitis treatment. The growing geriatric population is expected to have a key influence in driving demand for peri-implantitis treatment. The elderly population is expected to have a key influence in driving rising demand for peri-implantitis treatment during the period in analysis. Several dental procedures, such as dental grafting, have emerged from technological advancements, and are projected to provide lucrative possibilities for industry players in the peri-implantitis market. Growing tobacco use and smoking rates lead to a variety of oral disorders, which are predicted to drive peri-implantitis treatment growth over the forecast period. However, lack of skilled dental specialists is anticipated to restrain the growth of global peri-implantitis treatment market.
Global Peri-Implantitis Treatment Market – Overview
Peri-implantitis is a site-specific infection illness that causes soft tissue inflammation and bone loss around an Osseo integrated implant. Osseo integrated dental implants are becoming an increasingly popular treatment option for replacing missing or lost teeth. When employed to support various types of dental prosthesis, dental implants have a good rate of long-term survival (more than 10 years). However, long-term success of dental implants is not the same as survival, as functioning implants and their restorations may be prone to mechanical and biological difficulties. Smoking, poor oral hygiene, a history of periodontitis, biomechanical overload (due to high pressure and micro-fractures causing loss of osseointegration around the neck of the implant), poor quality bone, incorrect implant position, implant overloading, and diabetes are all major risk factors for peri-implantitis. The growing demand for dental implants in numerous dental treatments has resulted in disease problems, such as peri-implant mucositis and peri-implantitis. These disorders have an impact on the tissues around the implant, causing bone loss, and impairing implant function. Peri-implantitis is categorized into four stages based upon the degree of bone loss that has occurred in the implanted teeth. The dentist determines the treatment aim based on the degree of osseous involvement, such as halting disease progression or regeneration.
Impact of COVID-19 on Global Peri-Implantitis Treatment Market
COVID-19 had a detrimental effect on peri-implantitis treatment market due to various industries' operations have either been temporarily halted or are operating with a reduced staff due to enforced lockdowns and imposed limits by respective regulating bodies. Consumers across the globe have deliberately sought to avoid being in close quarters with others, particularly in medical institutions, and this is a factor that has stymied the global peri-implantitis treatment market. However, increased investments by key industry players in the development of enhanced product designs for better patient care are expected to generate potential revenue growth prospects for the global peri-implantitis treatment market.
Global Peri-Implantitis Treatment Market – By Method Type
By method type, global peri-implantitis treatment market is bifurcated into Surgical and Non-Surgical segments. The surgical segment is expected to hold a higher market share. The segment is sub-divided into bone regeneration, open flap debridement, and implantoplasty. The surgical procedure is considered the gold standard for the treatment of peri-implantitis, as it allows thorough debridement and cleaning of the implant affected. The advancements of technology, an increase in the number of dental treatments, and an increase in the geriatric population with tooth loss are all contributing to the rise of peri-implantitis.

Competitive Landscape
Major players operating in global peri-implantitis treatment market include Pfizer Inc., Cadila Pharmaceuticals, R.N. Laboratories Pvt. Ltd., Basic Pharma Life Science Pvt. Ltd., Prachi Pharmaceuticals Private Limited., Healthy Life Pharma., Neoss Limited, Dawood and Tanner, Credentis AG, Jiangsu Yenssen Biotech Co., Ltd., Sincerus Pharmaceuticals Inc., Small Lab Co., Ltd., Raphas Co., Ltd., Institut Straumann AG, Preserve Your Teeth Dentistry, 3M Company, Botiss biomaterials GmbH, and Geistlich Pharma Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Peri-Implantitis Treatment Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Peri-Implantitis Treatment Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

1. Research Framework: 1.1. Research Objective; 1.2. Peri-Implantitis Treatment Overview; 1.3. Market Segmentation
2. Executive Summary
3. Global Peri-implantitis Treatment Market Insights: 3.1. Industry Value Chain Analysis; 3.2. DROC Analysis; 3.2.1. Growth Drivers; 3.2.1.1. Rise in the number of oral diseases to drive the market; 3.2.1.2. Increase in prevalence of Peri-implantitis; 3.2.1.3. Adoption of advance oral technologies; 3.2.2. Restraints; 3.2.2.1. Lack of skilled dental specialists; 3.2.3. Opportunities; 3.2.3.1. Increase in tobacco use and smoking rates; 3.2.3.2. Technology advancements; 3.2.4. Challenges; 3.2.4.1. Difficult diagnosis; 3.2.4.2. Unawareness about the disease; 3.3. Recent Developments; 3.4. Regulatory Framework; 3.5. Porter’s Five Forces Analysis; 3.5.1. Bargaining Power of Suppliers; 3.5.2. Bargaining Power of Buyers; 3.5.3. Threat of New Entrants; 3.5.4. Threat of Substitutes; 3.5.5. Intensity of Rivalry
4. Global Peri-implantitis Treatment Market Overview: 4.1. Market Size & Forecast, 2019–2029; 4.1.1. By Value (USD Million); 4.2. Market Share & Forecast; 4.2.1. By Method Type; 4.2.1.1. Surgical; 4.2.1.1.1. Bone Regeneration; 4.2.1.1.2. Open Flap Debridement; 4.2.1.1.3. Implantoplasty; 4.2.1.2. Non-Surgical; 4.2.1.2.1. Mechanical Debridement; 4.2.1.2.2. Laser Debridement; 4.2.1.2.3. Antibiotics; 4.2.1.2.4. Others; 4.2.2. By End User; 4.2.2.1. Hospitals; 4.2.2.2. Dental Clinics; 4.2.2.3. Others; 4.2.3. By Region; 4.2.3.1. North America; 4.2.3.2. Europe; 4.2.3.3. Asia Pacific (APAC); 4.2.3.4. Latin America (LATAM); 4.2.3.5. Middle East and Africa (MEA)
5. North America Peri-implantitis Treatment Market: 5.1. Market Size & Forecast, 2019–2029; 5.1.1. By Value (USD Million); 5.2. Market Share & Forecast; 5.2.1. By Method Type; 5.2.2. By End User; 5.2.3. By Country; 5.2.3.1. US; 5.2.3.1.1. By Method Type; 5.2.3.1.2. By End User; 5.2.3.2. Canada; 5.2.3.2.1. By Method Type; 5.2.3.2.2. By End User
6. Europe Peri-implantitis Treatment Market: 6.1. Market Size & Forecast, 2019–2029; 6.1.1. By Value (USD Million); 6.2. Market Share & Forecast; 6.2.1. By Method Type; 6.2.2. By End User; 6.2.3. By Country; 6.2.3.1. Germany; 6.2.3.1.1. By Method Type; 6.2.3.1.2. By End User; 6.2.3.2. UK; 6.2.3.2.1. By Method Type; 6.2.3.2.2. By End User; 6.2.3.3. Italy; 6.2.3.3.1. By Method Type; 6.2.3.3.2. By End User; 6.2.3.4. France; 6.2.3.4.1. By Method Type; 6.2.3.4.2. By End User; 6.2.3.5. Spain; 6.2.3.5.1. By Method Type; 6.2.3.5.2. By End User; 6.2.3.6. The Netherlands; 6.2.3.6.1. By Method Type; 6.2.3.6.2. By End User; 6.2.3.7. Belgium; 6.2.3.7.1. By Method Type; 6.2.3.7.2. By End User; 6.2.3.8. NORDIC Countries; 6.2.3.8.1. By Method Type; 6.2.3.8.2. By End User; 6.2.3.9. Rest of Europe; 6.2.3.9.1. By Method Type; 6.2.3.9.2. By End User
7. Asia Pacific Peri-implantitis Treatment Market: 7.1. Market Size & Forecast, 2019–2029; 7.1.1. By Value (USD Million); 7.2. Market Share & Forecast; 7.2.1. By Method Type; 7.2.2. By End User; 7.2.3. By Country; 7.2.3.1. China; 7.2.3.1.1. By Method Type; 7.2.3.1.2. By End User; 7.2.3.2. India; 7.2.3.2.1. By Method Type; 7.2.3.2.2. By End User; 7.2.3.3. Japan; 7.2.3.3.1. By Method Type; 7.2.3.3.2. By End User; 7.2.3.4. South Korea; 7.2.3.4.1. By Method Type; 7.2.3.4.2. By End User; 7.2.3.5. Australia & New Zealand; 7.2.3.5.1. By Method Type; 7.2.3.5.2. By End User; 7.2.3.6. Indonesia; 7.2.3.6.1. By Method Type; 7.2.3.6.2. By End User; 7.2.3.7. Malaysia; 7.2.3.7.1. By Method Type; 7.2.3.7.2. By End User; 7.2.3.8. Singapore; 7.2.3.8.1. By Method Type; 7.2.3.8.2. By End User; 7.2.3.9. Philippines; 7.2.3.9.1. By Method Type; 7.2.3.9.2. By End User; 7.2.3.10. Vietnam; 7.2.3.10.1. By Method Type; 7.2.3.10.2. By End User; 7.2.3.11. Rest of Asia Pacific; 7.2.3.11.1. By Method Type; 7.2.3.11.2. By End User
8. Latin America Peri-implantitis Treatment Market: 8.1. Market Size & Forecast, 2019–2029; 8.1.1. By Value (USD Million); 8.2. Market Share & Forecast; 8.2.1. By Method Type; 8.2.2. By End User; 8.2.3. By Country; 8.2.3.1. Brazil; 8.2.3.1.1. By Method Type; 8.2.3.1.2. By End User; 8.2.3.2. Mexico; 8.2.3.2.1. By Method Type; 8.2.3.2.2. By End User; 8.2.3.3. Argentina; 8.2.3.3.1. By Method Type; 8.2.3.3.2. By End User; 8.2.3.4. Peru; 8.2.3.4.1. By Method Type; 8.2.3.4.2. By End User; 8.2.3.5. Colombia; 8.2.3.5.1. By Method Type; 8.2.3.5.2. By End User; 8.2.3.6. Rest of Latin America; 8.2.3.6.1. By Method Type; 8.2.3.6.2. By End User
9. Middle East & Africa Peri-implantitis Treatment Market: 9.1. Market Size & Forecast, 2019–2029; 9.1.1. By Value (USD Million); 9.2. Market Share & Forecast; 9.2.1. By Method Type; 9.2.2. By End User; 9.2.3. By Country; 9.2.3.1. Saudi Arabia; 9.2.3.1.1. By Method Type; 9.2.3.1.2. By End User; 9.2.3.2. UAE; 9.2.3.2.1. By Method Type; 9.2.3.2.2. By End User; 9.2.3.3. Qatar; 9.2.3.3.1. By Method Type; 9.2.3.3.2. By End User; 9.2.3.4. Kuwait; 9.2.3.4.1. By Method Type; 9.2.3.4.2. By End User; 9.2.3.5. Iran; 9.2.3.5.1. By Method Type; 9.2.3.5.2. By End User; 9.2.3.6. South Africa; 9.2.3.6.1. By Method Type; 9.2.3.6.2. By End User; 9.2.3.7. Nigeria; 9.2.3.7.1. By Method Type; 9.2.3.7.2. By End User; 9.2.3.8. Kenya; 9.2.3.8.1. By Method Type; 9.2.3.8.2. By End User; 9.2.3.9. Egypt; 9.2.3.9.1. By Method Type; 9.2.3.9.2. By End User; 9.2.3.10. Morocco; 9.2.3.10.1. By Method Type; 9.2.3.10.2. By End User; 9.2.3.11. Algeria; 9.2.3.11.1. By Method Type; 9.2.3.11.2. By End User; 9.2.3.12. Rest of MEA; 9.2.3.12.1. By Method Type; 9.2.3.12.2. By End User
10. Competitive Landscape: 10.1. List of Key Players and Their Offerings; 10.2. Global Peri-implantitis Treatment Company Market Share Analysis, 2022; 10.3. Competitive Benchmarking, By Operating Parameters; 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global Peri-implantitis Treatment Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis): 12.1. Pfizer Inc.; 12.2. Cadila Pharmaceuticals; 12.3. R.N. Laboratories Pvt. Ltd.; 12.4. Basic Pharma Life Science Pvt. Ltd.; 12.5. Prachi Pharmaceuticals Private Limited.; 12.6. Healthy Life Pharma.; 12.7. Neoss Limited; 12.8. Dawood and Tanner; 12.9. Credentis AG; 12.10. Jiangsu Yenssen Biotech Co., Ltd.; 12.11. Sincerus Pharmaceuticals Inc.; 12.12. Small Lab Co., Ltd.; 12.13. Raphas Co., Ltd.; 12.14. Institut Straumann AG; 12.15. Preserve Your Teeth Dentistry; 12.16. 3M Company; 12.17. Botiss biomaterials GmbH; 12.18. Geistlich Pharma Inc.; 12.19. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology: 14.1. Qualitative Research; 14.1.1. Primary & Secondary Research; 14.2. Quantitative Research; 14.3. Market Breakdown & Data Triangulation; 14.3.1. Secondary Research; 14.3.2. Primary Research; 14.4. Breakdown of Primary Research Respondents, By Region; 14.5. Assumptions & Limitations

Peri-implantitis Market by Type (Non-Surgical, Surgical), End-User (Dental Clinics, Hospitals) - Global Forecast 2024-2030

January, 2024 | Published by: 360iResearch | USD $4,749
Dental Laser Market, By Product Type (Soft Tissue Dental Lasers and All Tissue Dental Laser), By Application (Conservative Dentistry, Endodontic Treatment, Periodontics, Oral Surgery, Implantology, Peri-Implantitis, Tooth Whitening, and Others), By End User (Hospitals, Dental Clinics, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

February, 2023 | Published by: Coherent Market Insights | USD $4,500
Dental Autoclave Market, By Product Type (Semi-Automatic, Automatic, Manual), By End User (Hospitals, Dental Clinics, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

May, 2024 | Published by: Coherent Market Insights | USD $4,500
Dental Market, By Product Type (Preventive Care (Sterilants and Disinfectants, Sterilization Techniques, Waterline Treatment), Restorative Implants, Prosthetics, Endodontics, Dental Equipment), By End User (Dental Clinics, Hospitals, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

May, 2024 | Published by: Coherent Market Insights | USD $4,500
Body Fat Reduction Market, By Treatment Modality (Non-Invasive Treatments, Minimally Invasive Treatments and Surgical Treatments), By Target Body Area (Abdomen, Thighs, Hips and Buttocks, Arms, and Multiple Body Areas), By End User (Dermatology Clinics, Plastic Surgery Clinics, Hospitals and Ambulatory Surgical Centers, and Medical Spas and Beauty Clinics), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

August, 2024 | Published by: Coherent Market Insights | USD $4,500
PEEK Implants Market, By Application (Spinal Implants, Orthopedic Implants, Dental Implants, Craniomaxillofacial Implants, Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

November, 2023 | Published by: Coherent Market Insights | USD $4,500

PDF E-mail From Publisher:	$4,850
Multi User License (5-7 Users) Fulfilled by Publisher:	$5,750
Global Site License Fulfilled by Publisher:	$8,150

Peri-Implantitis Treatment Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Method Type (Surgical, Non-Surgical); By End User (Hospitals, Dental Clinics); By Region (North America, Europe, Asia Pacific,

Research Assistance

Other tasks

Peri-Implantitis Treatment Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Method Type (Surgical, Non-Surgical); By End User (Hospitals, Dental Clinics); By Region (North America, Europe, Asia Pacific,

Peri-implantitis Market by Type (Non-Surgical, Surgical), End-User (Dental Clinics, Hospitals) - Global Forecast 2024-2030

Dental Autoclave Market, By Product Type (Semi-Automatic, Automatic, Manual), By End User (Hospitals, Dental Clinics, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

PEEK Implants Market, By Application (Spinal Implants, Orthopedic Implants, Dental Implants, Craniomaxillofacial Implants, Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Research Assistance

Other tasks